6M4Q
Cytochrome P450 monooxygenase StvP2 substrate-free structure
6M4Q の概要
エントリーDOI | 10.2210/pdb6m4q/pdb |
分子名称 | Cytochrome P450, PROTOPORPHYRIN IX CONTAINING FE (3 entities in total) |
機能のキーワード | p450 anti-mrsa streptovaricin c methylenedioxy bridge stvp2 substrate-free structure, antibiotic |
由来する生物種 | Streptomyces spectabilis |
タンパク質・核酸の鎖数 | 1 |
化学式量合計 | 44467.84 |
構造登録者 | |
主引用文献 | Sun, G.,Hu, C.,Mei, Q.,Luo, M.,Chen, X.,Li, Z.,Liu, Y.,Deng, Z.,Zhang, Z.,Sun, Y. Uncovering the cytochrome P450-catalyzed methylenedioxy bridge formation in streptovaricins biosynthesis. Nat Commun, 11:4501-4501, 2020 Cited by PubMed Abstract: Streptovaricin C is a naphthalenic ansamycin antibiotic structurally similar to rifamycins with potential anti-MRSA bioactivities. However, the formation mechanism of the most fascinating and bioactivity-related methylenedioxy bridge (MDB) moiety in streptovaricins is unclear. Based on genetic and biochemical evidences, we herein clarify that the P450 enzyme StvP2 catalyzes the MDB formation in streptovaricins, with an atypical substrate inhibition kinetics. Furthermore, X-ray crystal structures in complex with substrate and structure-based mutagenesis reveal the intrinsic details of the enzymatic reaction. The mechanism of MDB formation is proposed to be an intramolecular nucleophilic substitution resulting from the hydroxylation by the heme core and the keto-enol tautomerization via a crucial catalytic triad (Asp89-His92-Arg72) in StvP2. In addition, in vitro reconstitution uncovers that C6-O-methylation and C4-O-acetylation of streptovaricins are necessary prerequisites for the MDB formation. This work provides insight for the MDB formation and adds evidence in support of the functional versatility of P450 enzymes. PubMed: 32908132DOI: 10.1038/s41467-020-18336-5 主引用文献が同じPDBエントリー |
実験手法 | X-RAY DIFFRACTION (1.35 Å) |
構造検証レポート
検証レポート(詳細版)をダウンロード